Holen Sie sich die Stockscreener-App
260.00
1.61%
-4.26
Handel nachbörslich:
260.00
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$264.26
Offen:
$262.18
24-Stunden-Volumen:
611.59K
Relative Volume:
0.80
Marktkapitalisierung:
$21.71B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
50.49
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
+0.50%
1M Leistung:
+4.90%
6M Leistung:
+13.94%
1J Leistung:
+28.25%
1-Tages-Spanne:
$258.72
$262.27
1-Wochen-Bereich:
$254.84
$265.72
52-Wochen-Spanne:
$198.96
$265.72
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
260.00 | 21.71B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
427.76 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
202.50 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
542.71 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
120.66 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
164.65 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-02 | Eingeleitet | Redburn Atlantic | Buy |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Stock Climbs 25.6% This Year: What's Driving the Surge? - Nasdaq
Labcorp Launches Labcorp Whole Health Solutions to Support Holistic Care - marketscreener.com
Labcorp Revolutionizes Healthcare Testing with New 1000+ Biomarker Platform for Holistic Medicine - Stock Titan
Baird Adjusts Price Target on Labcorp Holdings to $290 From $268, Maintains Outperform Rating - MarketScreener
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating - Yahoo Finance
FTRE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd Announces that Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Kaplan Fox Reminds Fortrea Holdings Inc. (FTRE) Investors of a Securities Class Action Deadline on August 1, 2025 - FinancialContent
Class Standing Issues Still Murky After Justices Punt LabCorp - Law360
Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus
Labcorp director Kerrii Anderson sells shares worth $130,000 By Investing.com - Investing.com Canada
Labcorp director Kerrii Anderson sells shares worth $130,000 - Investing.com Australia
Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - marketscreener.com
Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener
Kaplan Fox Encourages Investors of Fortrea Holdings Inc. (FTRE) to Contact the Firm Before Lead Plaintiff Deadline on August 1, 2025 - The Globe and Mail
Investing in Labcorp Holdings (NYSE:LH) five years ago would have delivered you a 85% gain - simplywall.st
Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq
Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - Yahoo Finance
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH St - GuruFocus
Kirby McInerney LLP Reminds Fortrea Holdings Inc. (FTRE) Investors of Class Action Filing and Encourages Investors to Contact the Firm - FinancialContent
Kaplan Fox Alerts Investors to a Securities Class Action Against Fortrea Holdings Inc. (FTRE)Deadline is August 1, 2025 - The Globe and Mail
Labcorp v. Davis Challenge Regarding Uninjured Class Members Dismissed as Improvidently Granted - Wilson Sonsini
What 8 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Just One Day Away – Register Now for HMG Strategy’s 9th Annual New York CISO & Technology Leadership Summit on June 12 - GlobeNewswire Inc.
Labcorp Hldgs (LH) Price Target Raised by Morgan Stanley | LH Stock News - GuruFocus
Analyst Boosts Price Target for Labcorp (LH) Amid Positive Growt - GuruFocus
Morgan Stanley Raises Price Target on Labcorp Holdings to $283 From $270 - marketscreener.com
LabCorp stock hits 52-week high at $258.7 amid robust growth By Investing.com - Investing.com South Africa
Justice Kavanaugh Signals One Conservative Vote in Labcorp Toward Imposing a Pre-Certification Standing Requirement Under FRCP 23 - The National Law Review
LabCorp stock hits 52-week high at $258.7 amid robust growth - Investing.com India
InStride Redefines Workforce Development Through Strategic Expansion - GlobeNewswire Inc.
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
SCOTUS Declines to Decide Fate of Classes with Uninjured Members: 8-1 Decision in LabCorp Leaves Unresolved Whether Rule 23 Allows Certification for a Class Containing Members Who Lack Standing - The National Law Review
SCOTUS DECLINES TO DECIDE FATE OF CLASSES WITH UNINJURED MEMBERS: 8-1 Decision In LabCorp Leaves Unresolved Whether Rule 23 Allows Certification For A Class Containing Members Who Lack Standing - TCPAWorld
Supreme Court backs off class-action case involving Labcorp, leaving legal questions unresolved - The Business Journals
Insider Sell: Brian Caveney Sells 2,000 Shares of Labcorp Holdin - GuruFocus
Should You Continue to Hold Labcorp Stock in Your Portfolio? - MSN
Labcorp EVP Brian Caveney sells $494,000 in common stock By Investing.com - Investing.com Canada
Labcorp EVP Brian Caveney sells $494,000 in common stock - Investing.com Australia
FTRE BREAKING NEWS: Fortrea Holdings Inc. Stock Plummets 25% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NASDAQ:FTRE) - Business Wire
High Court Drops Class Cert. Clarification Bid - Law360
Labcorp Holdings Insider Sold Shares Worth $494,000, According to a Recent SEC Filing - marketscreener.com
Fortrea Faces Investor Suit Over Post-Labcorp Financial Woes - Law360
FTRE INVESTOR ALERT: Fortrea Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead the Fortrea Class Action Lawsuit - The Malaysian Reserve
FTRE Stockholder Alert: Robbins LLP Informs Investors of the Fortrea Holdings, Inc. Class Action Lawsuit - Morningstar
Labcorp Adds New Tests for Solid Tumors, Hematologic Malignancies - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care, Advance Cancer Research - marketscreener.com
Labcorp Expands Oncology Portfolio to Improve Patient Care and A - GuruFocus
Labcorp (LH) Expands Precision Oncology Portfolio with New Offerings | LH Stock News - GuruFocus
Labcorp Expands Oncology Portfolio to Improve Patient Care and Advance Cancer Research - Financial Times
Labcorp Revolutionizes Cancer Care: New Test Portfolio Promises Faster Treatment Decisions - Stock Titan
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):